TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.32, sa.8, ss.661-666, 2021 (SCI-Expanded)
Background: Metabolic syndrome (MS) is a condition that consists of several disorders, and the individual impact of these disorders on metabolic dysfunction-associated fatty liver disease (MAFLD) is still not clear in a combined diagnosis of MS. In this study, we aimed to investigate the effect of MS on advanced fibrosis in patients with MAFLD.